Published on
March 12, 2026
- 14:50 GMT
FDA Foreign Inspection Gap Grows as U.S. Drug Imports Surge, New Study Finds
Foreign facilities failed FDA GMP inspections at up to 1.8x the U.S. rate. Journal of Pharmaceutical Innovation study quantifies a decade of oversight gaps. NEW YORK, NY, UNITED STATES, March 12, 2026 /EINPresswire.com/ -- A peer-reviewed study …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
